Found: 14
Select item for more details and to access through your institution.
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study †.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1018, doi. 10.3390/cancers14041018
- By:
- Publication type:
- Article
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Diffusivity changes in bevacizumab-responding and -refractory meningioma.
- Published in:
- 2017
- By:
- Publication type:
- Letter
"HEATPAC" - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nachsorge beim diffusen grosszeiligen B-Zell-Lymphom - Evidenz und Empfehlung.
- Published in:
- Praxis (16618157), 2018, v. 107, n. 1, p. 31, doi. 10.1024/1661-8157/a002861
- By:
- Publication type:
- Article
Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, n. 11, p. 560, doi. 10.1159/000441367
- By:
- Publication type:
- Article
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30950-z
- By:
- Publication type:
- Article
Decision-Making among Experts in Advanced Hodgkin Lymphoma.
- Published in:
- Oncology, 2023, v. 101, n. 3, p. 159, doi. 10.1159/000526360
- By:
- Publication type:
- Article
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R‐CHOP14: A SAKK 38/07 trial post‐hoc analysis.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 11, doi. 10.1002/hon.2935
- By:
- Publication type:
- Article
Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B‐cell lymphoma: post‐hoc analysis from the SAKK38/07 clinical trial.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 715, doi. 10.1002/hon.2805
- By:
- Publication type:
- Article
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0438-7
- By:
- Publication type:
- Article
Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-015-0168-7
- By:
- Publication type:
- Article
Multimodality Treatment in Ewing’s Sarcoma Family Tumors of the Maxilla and Maxillary Sinus: Review of the Literature.
- Published in:
- Sarcoma, 2016, p. 1, doi. 10.1155/2016/3872768
- By:
- Publication type:
- Article
Drug Conjugates Such as Antibody Drug Conjugates (ADCs), Immunotoxins and Immunoliposomes Challenge Daily Clinical Practice.
- Published in:
- International Journal of Molecular Sciences, 2012, v. 13, n. 12, p. 16020, doi. 10.3390/ijms131216020
- By:
- Publication type:
- Article